NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies

Oxidative Medicine and Cellular Longevity - United States
doi 10.1155/2016/4148791
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

WASF3 Provides the Conduit to Facilitate Invasion and Metastasis in Breast Cancer Cells Through HER2/HER3 Signaling

Oncogene
Cancer ResearchGeneticsMolecular Biology
2016English

Targeted Therapeutics in SLE: Emerging Strategies to Modulate the Interferon Pathway

Clinical and Translational Immunology
AllergyImmunologyNursing
2016English

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

Rho Signaling Pathway Targeted to Promote Spinal Cord Repair

Journal of Neuroscience
Neuroscience
2002English

A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy

Cancer Research
Cancer ResearchOncology
2008English

Corrigendum to “Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes”

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2018English

LBP Reduces Theinflammatory Injuryof Kidney in Septic Rat and Regulates the Keap1-Nrf2∕ARE Signaling Pathway

Acta Cirurgica Brasileira
Surgery
2019English

Myeloid-Targeted Immunotherapies Act in Synergy to Induce Inflammation and Antitumor Immunity

Journal of Experimental Medicine
MedicineAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy